S100B and ADMA in cerebral small vessel disease and cognitive dysfunction

Journal of the Neurological Sciences

Volumn 354, Issue 1-2, 2015, Pages 27-32

  Gao, Qiang ^a,b   Fan, Ying ^a   Mu, Lu Yan ^a   Ma, Lan ^a   Song, Zhi Qiang ^a   Zhang, Yi Na ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment   (China)

Author keywords

ADMA; Cerebral small vessel disease; Cognitive dysfunction; S100B

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; ORAL ANTIDIABETIC AGENT; PROTEIN S100B; ARGININE; BIOLOGICAL MARKER; N,N-DIMETHYLARGININE; S100B PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONAL ANISOTROPY; HEART DISEASE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MONTREAL COGNITIVE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BLOOD; CEREBRAL SMALL VESSEL DISEASES; COGNITION DISORDERS; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; SINGLE BLIND PROCEDURE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARGININE; BIOMARKERS; CEREBRAL SMALL VESSEL DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SINGLE-BLIND METHOD;

EID: 84937406989     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.04.031     Document Type: Article

References (58)

1. L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges Lancet Neurol 9 2010 689 701
2. S. Debette, and H.S. Markus The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis BMJ 341 2010 3666
3. S.E. Vermeer, W.T. Longstreth Jr., and P.J. Koudstaal Silent brain infarcts: a systematic review Lancet Neurol 6 2007 611 619
4. P.B. Gorelick, A. Scuteri, S.E. Black, C. Decarli, S.M. Greenberg, and C. Ladecola Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 2672 2713
5. R. Weber, C. Weimar, J. Blatchford, K. Hermansson, I. Wanke, C. Miller-Hartmann, and et al. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI substudy Stroke 43 2012 2336 2342
6. V.H. Ten Dam, D.M. van den Heuvel, M.A. van Buchem, R.G. Westendorp, E.L. Bollen, I. Ford, and et al. Effect of pravastatin on cerebral infarcts and white matter lesions Neurology 64 2005 1807 1809
7. SPS3 Investigators, O.R. Benavente, R.G. Hart, L.A. McClure, J.M. Szychowski, C.S. Coffey, and et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke N Engl J Med 367 2012 817 825
8. R.P. White, C. Hindley, P.M. Bloomfield, V.J. Cunningham, P. Vallance, D.J. Brooks, and et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study J Cereb Blood Flow Metab 19 1999 673 678
9. U. Khan, L. Porteous, A. Hassan, and H. Markus Risk factor profile of cerebral small vessel disease and its subtypes J Neurol Neurosurg Psychiatry 78 2007 702 706
10. R.H. Boger Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond Ann Med 38 2006 126 136
11. C.M. Fisher Lacunar strokes and infarcts: a review Neurology 32 1982 871 876
12. J. Steiner, H.G. Bernstein, B. Bogerts, T. Gos, C. Richter Landsberg, M.T. Wunderlich, and et al. S100B is expressed in, and released from, OLN-93 oligodendrocytes: influence of serum and glucose deprivation Neuroscience 154 2008 496 503
13. M. Rickmann, and J.R. Wolff S100 protein expression in subpopulations of neurons of rat brain Neuroscience 67 1995 977 991
14. Y. Zuo, J.L. Lubischer, H. Kang, L. Tian, M. Mikesh, A. Marks, and et al. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination J Neurosci 24 2004 10999 11009
15. D.E. Dietrich, U. Hauser, M. Peters, Y. Zhang, M. Wiesmann, M. Hasselmann, and et al. Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression Neurosci Lett 354 2004 69 73
16. K.R. Schmitt, C. Kern, P.E. Lange, F. Berger, H. Abdul Khaliq, and S. Hendrix S100B modulates IL-6 release and cytotoxicity from hypothermic brain cells and inhibits hypothermia-induced axonal outgrowth Neurosci Res 59 2007 68 73
17. M. Wiesmann, U. Missler, D. Gottmann, and S. Gehring Plasma S-100b protein concentration in healthy adults is age- and sex-independent Clin Chem 44 1998 1056 1058
18. Y. Seino, K. Nanjo, N. Tajima, T. Kadowaki, and A. Kashiwagi Report of the Committee on the classification and diagnostic criteria of diabetes mellitus Japan Diab Soc 53 2010 460 467
19. A.P. Appelman, K.L. Vincken, Y. van der Graaf, A.L. Vlek, T.D. Witkamp, W.P. Mali, and et al. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study Cerebrovasc Dis 29 2010 28 35
20. J.C. Van Swieten, A. Hijdra, P.J. Koudstaal, and J. van Gijn Grading white matter lesions on CT and MRI: a simple scale J Neurol Neurosurg Psychiatry 53 1990 1080 1083
21. F. Fazekas, J.B. Chawluk, A. Alavi, H.I. Hurtig, and R.A. Zimmerman MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging AJR Am J Roentgenol 149 1987 351 356
22. Z.S. Nasreddine, N.A. Phillips, V. Bédirian, S. Charbonneau, V. Whitehead, I. Collin, and et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment J Am Geriatr Soc 53 2005 695 699
23. T. Smith, N. Gildeh, and C. Holmes The Montreal Cognitive Assessment: validity and utility in a memory clinic setting Can J Psychiatry 52 2007 329 332
24. I.M. Popović, V. Serić, and V. Demarin Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease J Neurol Sci 257 2007 185 193
25. U. Khan, L. Porteous, A. Hassan, and H.S. Markus Risk factor profile of cerebral small vessel disease and its subtypes J Neurol Neurosurg Psychiatry 78 2007 702 706
26. N.D. Prins, E.J. van Dijk, T. den Heijer, S.E. Vermeer, J. Jolles, P.J. Koudstaal, and et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory Brain 128 2005 2034 2041
27. P.T. Ostrow, and L.L. Miller Pathology of small artery disease Adv Neurol 62 1993 93 123
28. H.J. Huttunen, J. Kuja-Panula, G. Sorci, A.L. Agneletti, R. Donato, and H. Rauvala Coregulation of neurite outgrowth and cell survival by amphotericin and S100 proteins through RAGE activation J Biol Chem 75 2000 40096 40105
29. S.S. Shaw, A.M. Schmidt, A.K. Banes, X. Wang, D.M. Stern, and M.B. Marrero S100B-RAGE-mediated augmentation of angiotensin II induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2 Diabetes 52 2003 2381 2388
30. K.T. Akama, and L.J. Van Eldik β-Amyloid stimulation of inducible nitric oxide synthase in astrocytes is IL-1β-, and TNF-α (TNFα)-dependent, and involves a TNFα receptor-associated factor-, and NF-κB-inducing kinase-dependent signaling mechanism J Biol Chem 275 2000 7918 7924
31. F. Fazekas, R. Kleinert, H. Offenbacher, R. Schmidt, G. Kleinert, F. Payer, and et al. Pathologic correlates of incidental MRI white matter signal hyperintensities Neurology 43 1993 1683 1689
32. M. Herrmann, and H. Ehrenreich Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring Restor Neurol Neurosci 21 2003 177 190
33. M. Rothermundt, M. Peters, J.H. Prehn, and V. Arolt S100B in brain damage and neurodegeneration Microsc Res Tech 60 2003 614 632
34. H.J. Huttunen, J. Kuja-Panula, G. Sorci, A.L. Agneletti, R. Donato, and H. Rauvala Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation J Biol Chem 275 2000 4006 4010
35. M.A. Mariggió, S. Fulle, P. Calissano, I. Nicoletti, and G. Fanó The brain protein S-100ab induces apoptosis in PC12 cells Neuroscience 60 1994 29 35
36. T.V. Petrova, J. Hu, and L.J. Van Eldik Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures Brain Res 8531 2000 74 80
37. C. Adami, G. Sorci, E. Blasi, A.L. Agneletti, F. Bistoni, and R. Donato S100B expression in and effects on microglia Glia 33 2001 131 142
38. K. Taya, C.R. Marmarou, K. Okuno, R. Prieto, and A. Marmarou Effect of secondary insults upon aquaporin-4 water channels following experimental cortical contusion in rats J Neurotrauma 27 2010 229 239
39. U. Khan, A. Hassan, P. Vallance, and H.S. Markus Asymmetric dimethylarginine in cerebral small vessel disease Stroke 38 2007 411 413
40. H.S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol 93 2007 121 127
41. M.S. Fernando, J.E. Simpson, F. Matthews, C. Brayne, C.E. Lewis, R. Barber, and et al. White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury Stroke 37 2006 1391 1398
42. P. Lacombe, C. Oligo, V. Domenga, E.T. Lasserve, and A. Joutel Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy Stroke 36 2005 1053 1058
43. A. Hassan, B. Hunt, M.O. Sullivan, R. Bell, R. D'Souza, and S. Jeffery Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction Brain 117 2004 212 219
44. K. Gormley, S. Bevan, and H.S. Markus Polymorphisms in genes of the renin angiotensin system and cerebral small vessel disease Cerebrovasc Dis 23 2006 148 155
45. J. Jia, A. Zhou, C. Wei, X. Jia, F. Wang, F. Li, and et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese Alzheimers Dement 10 2014 439 447
46. T. Erkinjuntti, A. Kurz, S. Gauthier, R. Bullock, S. Lillenfield, and C.V. Damaraju Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial Lancet 359 2002 1283 1290
47. E.J. van Dijk, N.D. Prins, H.A. Vrooman, and A. Hofman Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences. Rotterdam Scan Study Stroke 39 2008 2712 2719
48. P. Maillard, F. Crivello, C. Dufouil, N. Tzourio-Mazoyer, C. Tzourio, and B. Mazoyer Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly Neuroradiology 51 2009 209 220
49. A.A. Gouw, W.M. van der Flier, F. Fazekas, E.C. van Straaten, L. Pantoni, A. Poggesi, and et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability Study Stroke 39 2008 1414 1420
50. W.T. Longstreth Jr., A.M. Arnold, N.J. Beauchamp Jr., T.A. Manolio, D. Lefkowitz, C. Jungreis, and et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study Stroke 36 2005 56 61
51. L.C. Silbert, C. Nelson, D.B. Howieson, M.M. Moore, and A. JKaye Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline Neurology 77 2008 108 113
52. P. Gustavo, B. Warren, L. David, G.C. Maria, S. Qian, V. Daniel, and et al. The association of lacunar infarcts, medial temporal atrophy and cognition Alzheimers Dement 8 2012 597 598
53. R. Schmidt, S. Ropele, C. Enzinger, K. Petrovic, S. Smith, H. Schmidt, and et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian Stroke Prevention Study Ann Neurol 58 2005 610 616
54. M.A. Gruden, T.B. Davidova, M. Malisauskas, R.D. Sewell, N.I. Voskresenskaya, K. Wilhelm, and et al. Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Aβ(25-35) oligomers, S100b and neurotransmitters J Neuroimmunol 186 2007 181 192
55. H. Schmidt, and U. Walter NO at work Cell 78 1994 919 925
56. M. Rothermundt, M. Peters, J.H. Prehn, and V. Arolt S100b in brain damage and neurodegeneration Microse ResTeeh 60 2003 614 632
57. J.T. Kielstein, F. Donnerstag, S. Gasper, J. Menne, A. Kielstein, J. Martens-Lobenhoffer, and et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans Stroke 37 2006 2024 2029
58. A.K. Ali, W.A. Banks, V.B. Kumar, G.N. Shah, J.L. Lynch, S.A. Farr, and et al. Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments J Gerontol A Biol Sci Med Sci 64 2009 1025 1030